Drug
[18F]FAPI-74 PET/CT
[18F]FAPI-74 PET/CT is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
2
40%
Ph phase_1
1
20%
Ph phase_2
2
40%
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Completed(1)
Detailed Status
Recruiting3
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 32 (40.0%)
Trials by Status
not_yet_recruiting120%
recruiting360%
completed120%
Recent Activity
3 active trials
Showing 5 of 5
not_yet_recruitingphase_1
FAPI PET Imaging - An Exploratory Study
NCT07705074
recruitingphase_3
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07217717
recruitingphase_3
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
NCT07217704
completedphase_2
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
NCT05641896
recruitingphase_2
[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer
NCT07018661
Clinical Trials (5)
Showing 5 of 5 trials
NCT07705074Phase 1
FAPI PET Imaging - An Exploratory Study
NCT07217717Phase 3
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07217704Phase 3
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
NCT05641896Phase 2
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
NCT07018661Phase 2
[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5